Bimzelx 320 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB26FTFVG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,261
Award facts
- Contract value 100% obligated
- $50,261.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $50,261.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of BIMZELX 320 mg/2 ml auto-injector units. BIMZELX is a prescription biologic medication used to treat moderate to severe plaque psoriasis and other inflammatory conditions. The contract is non-set-aside and competitively awarded, with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of October 29, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the prime vendor vehicle for global pharmaceutical support to military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a significant federal contracting presence as a critical supplier to the Defense Logistics Agency's Medical Supply Chain and the Defense Health Agency. The company's extensive portfolio of federal contracts demonstrates expertise in delivering brand-name and generic pharmaceuticals, specialty medications, vaccines, and medical devices across multiple therapeutic domains to support military and veteran healthcare systems. This specific delivery order reflects the company's ongoing role in fulfilling specialized pharmaceutical procurement requirements for federal military medical operations.
Quick answers
Who was awarded contract SPE2DB26FTFVG?
SPE2DB26FTFVG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FTFVG worth?
The government has obligated $50,261 on SPE2DB26FTFVG.
Is contract SPE2DB26FTFVG an order under another contract?
Yes. SPE2DB26FTFVG is a delivery order under SPE2DB25D2204, an indefinite delivery contract.
Was contract SPE2DB26FTFVG competed?
The extent of competition for SPE2DB26FTFVG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award